We are a human innovation company on a mission to improve the lives of millions of people.

A human innovation company.

Brighter addresses common public health challenges. By introducing groundbreaking technology and innovative services, Brighter aims to improve health outcomes and wellbeing amongst the global population and facilitate increased efficiency throughout the healthcare system. Currently Brighter and it’s subsidiary Nectarine Health have offices in Stockholm, Dubai, New York and Jakarta. Brighter’s shares are listed on Nasdaq First North Growth Market (“BRIG”).

Tackling diabetes first.

We are currently focused on addressing the global diabetes epidemic, introducing Actiste® Diabetes Management as a Service. Diabetes is one of the world’s fastest-growing chronic conditions, affecting more than 537 million adults worldwide, with the number set to rise to 783 million by 2045.

Data-driven diabetes care.

The trend in diabetes care is to provide patients with ways to better manage their own treatment, and thereby ease the burden on healthcare systems. We have created Actiste – Diabetes Management as a Service to meet this global need. Read all about it here.

Future opportunities.

While Actiste is our current focus, we believe the health data generated through this area and other initiatives we are involved in will provide a solid base for further business opportunities in clinical care and research.